Skip to main navigation
Skip to search
Skip to main content
Manipal Academy of Higher Education, Manipal, India Home
Help & FAQ
Home
Profiles
Research units
Research output
Equipment
Search by expertise, name or affiliation
Nimotuzumab-induced hypertension: A maiden case report
Ommurugan Balaji
, D. Amita Priya
, Navin Patil
*
*
Corresponding author for this work
Department of Pharmacology, Kasturba Medical College, Manipal
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nimotuzumab-induced hypertension: A maiden case report'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
hypertension
100%
cancer
66%
receptors
66%
growth factors
66%
monoclonal antibodies
66%
cuba
66%
argentina
66%
india
33%
gliomas
33%
carcinomas
33%
china
33%
men
33%
ukraine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Nimotuzumab
100%
Epidermal Growth Factor Receptor
66%
Monoclonal Antibody
66%
Bevacizumab
33%
Malignant Neoplasm
33%
Larynx Carcinoma
33%
Cetuximab
33%
Nasopharynx Cancer
33%